Motilal Oswal's research report on MCX
MCX posted 57% YoY growth in operating revenue, reaching INR3b (5% miss) in 3QFY25. Operating revenue rose 63% YoY to INR8.2b in 9MFY25. EBIT stood at INR1.8b vs EBIT loss of INR310m in 3QFY24, a 6% miss on our estimates. The company reported PAT of INR1.6b (vs loss of INR54m in 3QFY24), flat QoQ, and was 7% lower than our estimates. For 9MFY25, PAT stood at INR4.2b. The quarter reported healthy volumes with an overall jump of 102% YoY (futures volumes grew 32% YoY and options volumes surged 116% YoY). The management has guided for this momentum to sustain, driven by: 1) new product launches, 2) increasing participation, 3) awareness programs, and 4) exploration of new commodity areas.
Outlook
We have cut our EPS estimates by 4%/14%/11% for FY25/26/27. The launch of serial contracts on crude oil will be vital for the re-rating of the stock. We maintain a Neutral rating on the stock with a one-year TP of INR6,100 (premised on 38x Sep’26E EPS).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!